Skip to content

Researcher retraction Influence of autologous bone and artificial bone on clinical efficacy and fusion rate in posterior lumbar surgery: A prospective randomized controlled clinical trial

Influence of autologous bone and artificial bone on clinical efficacy and fusion rate in posterior lumbar surgery: A prospective randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091647
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal degenerative diseases

Interventions

Autologous bone group:For posterior lumbar surgery, in the autologous bone group, autologous bone obtained from the patients own ilium or spinous process is used for fusion through bone grafting on th
Allogeneic bone group:For posterior lumbar surgery, in the artificial bone group, commercial artificial bone is used for fusion through bone grafting on the lamina.

Sponsors

Xi'an Honghui Hospital Affiliated to Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who need posterior lumbar surgery due to diseases such as lumbar disc herniation, lumbar spinal stenosis, lumbar spondylolisthesis and lumbar fractures; (2) Patients aged between 18 and 75 years old; (3) Patients who agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of lumbar spine surgery; (2) Patients with severe internal diseases that cannot tolerate surgery; (3) Patients with a history of allergy to autologous bone or artificial bone; (4) Patients with tumors or mental disorders; (5) Patients who cannot cooperate to complete follow-up; (6) Patients who are participating in other research projects.

Design outcomes

Primary

MeasureTime frame
Pain status;Bone fusion rate;

Countries

China

Contacts

Public ContactJinwen Zhu

Xi'an Honghui Hospital Affiliated to Xi'an Jiaotong University

jeven801208@163.com+86 152 2935 9513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026